文献速递脑血管病

NT-proBNP在缺血性卒中后房颤检测中的作用:时间依赖性关系

Role of NT-proBNP for Atrial Fibrillation Detection After Ischemic Stroke: A Time-Dependent Relationship.
PubMed 文献 · Stroke · 2025-04-21

该研究基于BIOSIGNAL和Graz卒中通路研究的汇总数据,纳入2292例缺血性卒中患者,评估入院NT-proBNP对院内及出院后新发房颤(AFDAS)的预测价值。结果显示NT-proBNP对院内AFDAS预测能力良好(AUC 0.83), cutoff 505 pg/mL灵敏度82%、特异度71%、阴性预测值96%;但对出院后AFDAS预测能力有限(AUC 0.65)。

要点

  • 入院NT-proBNP预测院内AFDAS的AUC为0.83,预测出院后AFDAS的AUC仅0.65。
  • NT-proBNP cutoff 505 pg/mL对院内AFDAS灵敏度82%、特异度71%、阴性预测值96%。
  • 出院后诊断AFDAS的患者中20%入院NT-proBNP正常(<125 pg/mL)。

核心结论

  • 在缺血性卒中患者中,入院NT-proBNP cutoff 505 pg/mL似乎是院内AFDAS的可靠预测指标,而对出院后AFDAS的预测能力有限。

研究设计与样本

  • 研究为BIOSIGNAL前瞻性国际多中心队列研究(欧洲卒中中心,2014年10月至2017年10月)与Graz前瞻性单中心卒中通路研究(奥地利,2018年5月至2020年8月)的汇总数据分析。
  • 共纳入2292例缺血性卒中患者,中位年龄74岁,42%为女性;AFDAS定义为入院后1年内诊断的≥30秒房颤/房扑,分为院内和出院后。
  • NT-proBNP在症状发作后≤24小时内评估;采用多变量logistic回归分析其与AFDAS的关联。

主要发现

  • 2292例患者中374例(16%)诊断为AFDAS,其中268例(72%)在住院期间诊断,106例(28%)在出院后诊断(中位住院时间15天)。
  • 入院NT-proBNP对院内AFDAS的预测能力良好,AUC为0.83(95% CI 0.81-0.86)。
  • 对出院后诊断的AFDAS,NT-proBNP预测能力较差,AUC为0.65(95% CI 0.60-0.70),且20%的患者入院NT-proBNP正常(<125 pg/mL)。
  • NT-proBNP cutoff 505 pg/mL对院内AFDAS的灵敏度为82%,特异度为71%,阴性预测值为96%。

关键数值与推荐

  • AFDAS定义:入院后1年内诊断的≥30秒房颤/房扑。
  • NT-proBNP评估时间:症状发作后≤24小时。
  • NT-proBNP cutoff 505 pg/mL对院内AFDAS:灵敏度82%,特异度71%,阴性预测值96%。
  • NT-proBNP正常值定义为<125 pg/mL。

临床怎么用

  • 入院NT-proBNP cutoff 505 pg/mL似乎可用于辅助识别院内AFDAS高风险患者,其阴性预测值达96%。
  • 对出院后AFDAS的预测能力有限,20%出院后诊断AFDAS的患者入院NT-proBNP正常。
  • 研究结果可能影响未来二级卒中预防试验的设计。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Atrial fibrillation detected after stroke (AFDAS) affects secondary stroke prevention, yet identification can be challenging. Easily accessible cardiac blood biomarkers such as NT-proBNP (N-terminal pro-B-type natriuretic peptide) could guide diagnostic workup, but optimal cutoff values and the time-dependent relationship between NT-proBNP and AFDAS are unclear. We aimed (1) to externally validate earlier presented NT-proBNP cutoffs for atrial fibrillation prediction and (2) to assess the time-dependent relationship of NT-proBNP and early in-hospital AFDAS versus AFDAS after discharge. METHODS: We conducted a pooled data analysis of patients with ischemic stroke from the prospective international multicenter BIOSIGNAL (Biomarker Signature of Stroke Aetiology) cohort study (European Stroke Centers from October 2014 to October 2017) and the prospective single-center Graz stroke pathway study (Austria from May 2018 to August 2020). AFDAS was defined as ≥30-s atrial fibrillation/flutter diagnosed within 1 year post-admission and categorized in in-hospital versus after discharge. NT-proBNP was assessed ≤24 hours of symptom onset. The association between NT-proBNP and AFDAS was evaluated by a multivariable logistic regression analysis. RESULTS: AFDAS was diagnosed in 374 (16%) of 2292 patients with ischemic stroke (median age, 74 years; 42% female), 268 (72%) during hospitalization, and 106 (28%) after discharge (median duration of hospitalization, 15 days). NT-proBNP levels at admission had a good predictive capacity for in-hospital AFDAS (area under the receiver operating characteristic curve, 0.83 [95% CI, 0.81-0.86]). For patients diagnosed with AFDAS after discharge, the predictive capacity of NT-proBNP was poor (area under the receiver operating characteristic curve, 0.65 [95% CI, 0.60-0.70]), and 20% had normal NT-proBNP values <125 pg/mL at admission. The NT-proBNP cutoff of 505 pg/mL exhibited high sensitivity (82%) and specificity (71%) for in-hospital AFDAS, with a negative predictive value of 96%. CONCLUSIONS: In patients with ischemic stroke, the admission NT-proBNP cutoff of 505 pg/mL seems to be a reliable predictor for in-hospital AFDAS, while the predictive capacity of NT-proBNP for AFDAS after discharge is limited. Our results might influence the designs of future secondary stroke prevention trials.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Hatab I, Kneihsl M, Arnold M, et al. Role of NT-proBNP for Atrial Fibrillation Detection After Ischemic Stroke: A Time-Dependent Relationship. Stroke. 2025. PMID: 40255172. doi:10.1161/STROKEAHA.124.049249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。